AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in AIM ImmunoTech Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −5 vs. Q4 2021
- Shares held
- 6.72M
- −747.2K (−10.0%) vs. Q4 2021
- Total value
- $7.12M
- +$258.9K (+3.8%) vs. Q4 2021
- New holders
- 2
- 5 more added
- Sold out
- 7
- 15 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $325.6K |
| Q1 2026 | 18 | $102.8K |
| Q4 2025 | 13 | $119.8K |
| Q3 2025 | 15 | $293.9K |
| Q2 2025 | 12 | $104.8K |
| Q1 2025 | 34 | $590.0K |
| Q4 2024 | 35 | $919.3K |
| Q3 2024 | 33 | $2.43M |
| Q2 2024 | 36 | $3.15M |
| Q1 2024 | 33 | $1.93M |
| Q4 2023 | 38 | $1.83M |
| Q3 2023 | 38 | $1.97M |
| Q2 2023 | 34 | $3.01M |
| Q1 2023 | 36 | $2.05M |
| Q4 2022 | 39 | $1.67M |
| Q3 2022 | 38 | $3.36M |
| Q2 2022 | 40 | $4.68M |
| Q1 2022 | 38 | $7.12M |
| Q4 2021 | 43 | $6.86M |
| Q3 2021 | 38 | $14.7M |
| Q2 2021 | 39 | $15.5M |
| Q1 2021 | 38 | $16.8M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,992,129 | $2.11M | 0.00% | −49,253−2.4% | Reduced |
| Vanguard Group Inc | 1,987,595 | $2.11M | 0.00% | −12,690−0.6% | Reduced |
| BlackRock Inc. | 828,543 | $878.0K | 0.00% | −5,760−0.7% | Reduced |
| Renaissance Technologies LLC | 428,071 | $454.0K | 0.00% | −277,029−39.3% | Reduced |
| Geode Capital Management, LLC | 372,953 | $395.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 173,103 | $183.0K | 0.00% | +12,690+7.9% | Added |
| Bridgeway Capital Management, LLC | 161,000 | $171.0K | 0.00% | −55,000−25.5% | Reduced |
| Verition Fund Management LLC | 153,000 | $162.0K | 0.00% | −9,000−5.6% | Reduced |
| Price T Rowe Associates Inc | 116,800 | $124.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 88,707 | $94.0K | 0.00% | +45+0.1% | Added |
| Dimensional Fund Advisors LP | 83,557 | $89.0K | 0.00% | −217,740−72.3% | Reduced |
| Virtu Financial LLC | 50,805 | $54.0K | 0.00% | +13,148+34.9% | Added |
| Cambridge Investment Research Advisors, Inc. | 46,678 | $49.0K | 0.00% | +46,678 | New |
| Rockefeller Capital Management L.P. | 40,000 | $42.0K | 0.00% | 00.0% | Unchanged |
| SeaCrest Wealth Management, LLC | 40,063 | $42.0K | 0.00% | +1,500+3.9% | Added |
| Bank of New York Mellon Corp | 27,565 | $29.0K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 20,000 | $21.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 16,482 | $17.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 15,001 | $16.0K | 0.00% | −88−0.6% | Reduced |
| Millennium Management LLC | 13,033 | $14.0K | 0.00% | +63+0.5% | Added |
| Community Bank, N.A. | 13,226 | $14.0K | 0.00% | 00.0% | Unchanged |
| Traynor Capital Management, Inc. | 11,777 | $12.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,286 | $11.0K | 0.00% | −1,508−12.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 10,800 | $11.0K | 0.00% | −300−2.7% | Reduced |
| SNS Financial Group, LLC | 10,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Howe & Rusling Inc | 1,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Stephens Consulting, LLC | 1,500 | $1.59K | 0.00% | −1,500−50.0% | Reduced |
| Advisor Group Holdings, Inc. | 1,455 | $1.00K | 0.00% | −2,000−57.9% | Reduced |
| Hoey Investments, Inc | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Proequities, Inc. | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cordasco Financial Network | 500 | $1.00K | 0.00% | +500 | New |
| American Portfolios Advisors | 228 | $242 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 170 | $226 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 201 | $0 | 0.00% | −4,671−95.9% | Reduced |
| JPMorgan Chase & Co | 3 | $0 | 0.00% | −2,617−99.9% | Reduced |
| Huntington National Bank | 57 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6 | $0 | 0.00% | −4−40.0% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −48,450−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −41,052−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −37,812−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −24,035−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,499−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −15,693−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |